AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,698 | +1.8% | 4,560 | +4.7% | 0.00% | 0.0% |
| Q2 2023 | $312,950 | +12.4% | 4,355 | -3.5% | 0.00% | 0.0% |
| Q1 2023 | $278,362 | -8.8% | 4,513 | +14.1% | 0.00% | -33.3% |
| Q4 2022 | $305,203 | -18.2% | 3,957 | -59.3% | 0.00% | 0.0% |
| Q2 2022 | $373,000 | +64.3% | 9,734 | +77.3% | 0.00% | +200.0% |
| Q1 2022 | $227,000 | -63.2% | 5,491 | -66.4% | 0.00% | -66.7% |
| Q4 2021 | $617,000 | +7.5% | 16,342 | -6.2% | 0.00% | -25.0% |
| Q3 2021 | $574,000 | +137.2% | 17,418 | +384.8% | 0.00% | +100.0% |
| Q2 2021 | $242,000 | -25.5% | 3,593 | -9.8% | 0.00% | -33.3% |
| Q4 2020 | $325,000 | +12.1% | 3,984 | -2.1% | 0.00% | -25.0% |
| Q3 2020 | $290,000 | -14.7% | 4,069 | -1.6% | 0.00% | -20.0% |
| Q2 2020 | $340,000 | -27.7% | 4,135 | -9.0% | 0.01% | -28.6% |
| Q4 2019 | $470,000 | +80.8% | 4,545 | -64.6% | 0.01% | +75.0% |
| Q3 2019 | $260,000 | – | 12,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |